Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function
Cha Lin, Hao Wu, Wenbiao Xian, Yifan Zheng et autres
5 citationsEBioMedicine
Peter J. Snyder
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
209Publications signalées
22693Citations signalées
0Affiliations récentes
Domaines associés
Hormonal and reproductive studiesPituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsSexual function and dysfunction studiesBone health and osteoporosis research
Publications récentes
Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment
Beverly M. K. Biller, Alessandra Casagrande, Атанаска Еленкова, César Luiz Boguszewski et autres
12 citationsThe Journal of Clinical Endocrinology & Metabolism
MON-069 Once-daily Oral Paltusotine In The Treatment Of Patients With Biochemically Uncontrolled Acromegaly: Interim Results Of The PATHFNDR-2 Open-label Extension
Mônica R. Gadelha, Alessandra Casagrande, Атанаска Еленкова, César Luiz Boguszewski et autres
1 citationJournal of the Endocrine Society
OR12-07 Disease Control in Patients With Acromegaly Switching From Injected Somatostatin Receptor Ligands to Once-Daily Oral Paltusotine: Interim Results of the PATHFNDR-1 Open-Label Extension
Beverly M. K. Biller, Alessandra Casagrande, Christian J. Strasburger, Martin Bidlingmaier et autres
1 citationJournal of the Endocrine Society
Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism
Shalender Bhasin, Peter J. Snyder
19 citationsNew England Journal of Medicine
Testosterone Treatment of Late-Onset Hypogonadism: Benefits and Risks
0 citations
Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone Diseases
E. Michael Lewiecki, John P. Bilezikian, Michael T. Collins, Deborah M. Kado et autres
4 citationsJournal of Clinical Densitometry
12535 Efficacy And Safety Of Once-daily Oral Paltusotine In Medically Untreated Patients With Acromegaly: Results From The Phase 3, Randomized, Placebo-controlled Pathfndr-2 Study
Beverly M. K. Biller, Alessandra Casagrande, Атанаска Еленкова, César Luiz Boguszewski et autres
13 citationsJournal of the Endocrine Society
8404 Use of the Acromegaly Symptom Diary (ASD) in a Phase 3, Placebo-Controlled Study of Once-Daily, Oral Paltusotine in Patients With Acromegaly Switched From Injected Octreotide or Lanreotide
Mônica R. Gadelha, Alessandra Casagrande, Christian J. Strasburger, Martin Bidlingmaier et autres
0 citationsJournal of the Endocrine Society
Modulation of circulating free testosterone fraction by testosterone, dihydrotestosterone, and estradiol during testosterone replacement therapy
Ravi Jasuja, Karol M. Pencina, Brian Lawney, Alisa J. Stephens‐Shields et autres
6 citationsAndrology
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine
Mônica R. Gadelha, Alessandra Casagrande, Christian J. Strasburger, Martin Bidlingmaier et autres
42 citationsThe Journal of Clinical Endocrinology & Metabolism
Testosterone Treatment and Fractures in Men with Hypogonadism
Peter J. Snyder, Douglas C. Bauer, Susan S. Ellenberg, Jane A. Cauley et autres
132 citationsNew England Journal of Medicine
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.